Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry
Circulation: Cardiovascular Interventions · 2026
DOI: 10.1161/circinterventions.125.016068 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026. Verfasst von Bhavanadhar Penta und 59 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Health System, New York, NY (B.P., G.H.L.T.). Hauptthemen laut MEDLINE: Aortic Valve, Device Removal, Prosthesis Failure, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: As transcatheter aortic valve replacement (TAVR) expands to patients with longer life expectancy, the impact of failure mechanisms on outcomes of TAVR-explant and redo-TAVR remains uncertain. We sought to evaluate outcomes of TAVR reintervention based on the failure mechanism of the index transcatheter aortic valve. METHODS: From 2009 to 2022, 553 patients from 29 centers in the EXPLANTORREDO-TAVR registry (Explant or Redo Transcatheter Aortic Valve Replacement) underwent TAVR-explant or redo-TAVR for transcatheter aortic valve failure. Patients with endocarditis were excluded. Patients with structural valve deterioration (SVD, N=224 [64.9%]) were compared with those with nonstructural valve dysfunction (NSVD, N=121 [35.1%]), comprising paravalvular leak (86.0%) and prosthesis-patient mismatch (14.0%). Outcomes were assessed at 30 days and 1 year. RESULTS: Mean age was 75.6±9.3 years, with 42% women. There were no differences in reintervention type between groups (redo-TAVR in 58.0% SVD versus 49.6% NSVD; TAVR-explant: 42.0% versus 50.4%; P =0.14). Compared with NSVD, SVD was the predominant mode of failure in balloon-expandable valves (50.7% versus 24.8%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mount Sinai Health System, New York, NY (B.P., G.H.L.T.).
- Leipzig Heart Center, Germany (M.A.-W., P.K., M.M.-C.).
- Erasmus University Medical Center, Rotterdam, The Netherlands (R.A., T.W.H., N.M.V.M.).
- Westchester Medical Center, Valhalla, NY (H.A.).
- Medical University of Vienna, Austria (M.A., M.M.).
- Northwestern Medicine, Chicago, IL (A.W.A.).
ORCID-Profile: Bhavanadhar Penta, Gilbert H L Tang, Mohamed Abdel-Wahab, Rik Adrichem, Hasan Ahmad, Martin Andreas, Anita W Asgar, Igor Belluschi, Anson Cheung, Andrea Colli, Lenard Conradi, Ole De Backer, Paolo Denti, Nimesh D Desai, J Michael DiMaio, John K Forrest, Shinichi Fukuhara, Arnar Geirsson, Sachin S Goel, Joshua B Goldberg, Howard C Herrmann, Thijmen W Hokken, Neal S Kleiman, Markus Mach, Mateo Marin-Cuartas, David Meier, Thomas Modine, George Petrossian, Luigi Pirelli, Basel Ramlawi, Hendrik Ruge, Shekhar Saha, Christian C Schults, Emily Shih, Molly Szerlip, Axel Unbehaun, Nicolas M Van Mieghem, Keti Vitanova, Ron Waksman, John G Webb, Moritz C Wyler von Ballmoos, Michael J Reardon, Tamim N Nazif, Martin B Leon, Michael J Mack, Tsuyoshi Kaneko, Vinayak N Bapat, Syed Zaid
Zitieren
APA
Penta, B., Tang, G. H. L., Abdel-Wahab, M., Adrichem, R., Ahmad, H., Andreas, M., Asgar, A. W., Belluschi, I., Ben-Ali, W., Bhadra, O. D., Cheung, A., Colli, A., Conradi, L., Corona, S., De Backer, O., Denti, P., Desai, N. D., Di Eusanio, M., DiMaio, J. M., …, & Zaid, S. (2026). Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry. Circulation: Cardiovascular Interventions. https://doi.org/10.1161/circinterventions.125.016068
Vancouver
Penta B, Tang GHL, Abdel-Wahab M, Adrichem R, Ahmad H, Andreas M, et al. Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry. Circulation: Cardiovascular Interventions. 2026. doi:10.1161/circinterventions.125.016068
BibTeX
@article{Penta2026,
author = {Penta, Bhavanadhar and Tang, Gilbert H L and Abdel-Wahab, Mohamed and Adrichem, Rik and Ahmad, Hasan and Andreas, Martin and Asgar, Anita W and Belluschi, Igor and Ben-Ali, Walid and Bhadra, Oliver D and Cheung, Anson and Colli, Andrea and Conradi, Lenard and Corona, Silvia and De Backer, Ole and Denti, Paolo and Desai, Nimesh D and Di Eusanio, Marco and DiMaio, J Michael and Forrest, John K and Fukuhara, Shinichi and Geirsson, Arnar and Goel, Sachin S and Goldberg, Joshua B and Hagl, Christian and Herrmann, Howard C and Hokken, Thijmen W and Kempfert, Jorg and Kiefer, Philipp and Kleiman, Neal S and Kliger, Chad and Mach, Markus and Marin-Cuartas, Mateo and Meier, David and Modine, Thomas and Petrossian, George and Pirelli, Luigi and Ramlawi, Basel and Robinson, Newell B and Rovin, Joshua D and Ruge, Hendrik and Saha, Shekhar and Schults, Christian C and Shih, Emily and Szerlip, Molly and Taramasso, Maurizio and Unbehaun, Axel and Van Mieghem, Nicolas M and Vitanova, Keti and Waksman, Ron and Wang, Lin and Webb, John G and Wyler von Ballmoos, Moritz C and Reardon, Michael J and Nazif, Tamim N and Leon, Martin B and Mack, Michael J and Kaneko, Tsuyoshi and Bapat, Vinayak N and Zaid, Syed},
title = {Impact of TAVR Failure Mechanism on Outcomes After Reintervention: From the EXPLANTORREDO-TAVR Registry},
journal = {Circulation: Cardiovascular Interventions},
year = {2026},
doi = {10.1161/circinterventions.125.016068}
}
EUVIMED